×

News publications and other organizations are encouraged to reuse Direct Relief-published content for free under a Creative Commons License (Attribution-Non-Commercial-No Derivatives 4.0 International), given the republisher complies with the requirements identified below.

When republishing:

  • Include a byline with the reporter’s name and Direct Relief in the following format: "Author Name, Direct Relief." If attribution in that format is not possible, include the following language at the top of the story: "This story was originally published by Direct Relief."
  • If publishing online, please link to the original URL of the story.
  • Maintain any tagline at the bottom of the story.
  • With Direct Relief's permission, news publications can make changes such as localizing the content for a particular area, using a different headline, or shortening story text. To confirm edits are acceptable, please check with Direct Relief by clicking this link.
  • If new content is added to the original story — for example, a comment from a local official — a note with language to the effect of the following must be included: "Additional reporting by [reporter and organization]."
  • If republished stories are shared on social media, Direct Relief appreciates being tagged in the posts:
    • Twitter (@DirectRelief)
    • Facebook (@DirectRelief)
    • Instagram (@DirectRelief)

Republishing Images:

Unless stated otherwise, images shot by Direct Relief may be republished for non-commercial purposes with proper attribution, given the republisher complies with the requirements identified below.

  • Maintain correct caption information.
  • Credit the photographer and Direct Relief in the caption. For example: "First and Last Name / Direct Relief."
  • Do not digitally alter images.

Direct Relief often contracts with freelance photographers who usually, but not always, allow their work to be published by Direct Relief’s media partners. Contact Direct Relief for permission to use images in which Direct Relief is not credited in the caption by clicking here.

Other Requirements:

  • Do not state or imply that donations to any third-party organization support Direct Relief's work.
  • Republishers may not sell Direct Relief's content.
  • Direct Relief's work is prohibited from populating web pages designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
  • Advance permission is required to translate Direct Relief's stories into a language different from the original language of publication. To inquire, contact us here.
  • If Direct Relief requests a change to or removal of republished Direct Relief content from a site or on-air, the republisher must comply.

For any additional questions about republishing Direct Relief content, please email the team here.

300 Ugandan Children to Receive Treatment for Burkitt’s Lymphoma

News

By Staff

Today the Burkitt’s Lymphoma Fund for Africa  and Direct Relief announced that UPCID Ltd (a collaboration between the Fred Hutchinson Cancer Research Center and the Uganda Cancer Institute) was selected to receive grant funds and medicine to treat 300 Ugandan children for Burkitt’s lymphoma for two years at the Uganda Cancer Institute in Kampala.

Burkitt’s lymphoma is a life-threatening malignancy and is the most common cancer for children living in Uganda. The average age of a child with the disease is five. A fast-growing tumor often develops in the jaw or abdomen that can interfere with breathing and make it difficult for young patients to feed adequately, leading to malnutrition. Currently, the five-year survival rate in Uganda is less than 40 percent.

“More than 85 percent of these children could be cured for less than $600 a case,” said Corey Casper, M.D., M.P.H., associate member of the Hutchinson Center’s Vaccine and Infectious Disease Division and co-scientific director of the UCI/Hutchinson Center Cancer Alliance.

Following a competitive selection process, Seattle-based Burkitt’s Lymphoma Fund for Africa (BLFA) awarded UPCID a grant of $128,000 to cover a variety of costs for patient care and treatment.  In total, two East African organizations were selected to receive these initial grants from BLFA: UPCID and the OGRA Foundation in Kenya.

“Burkitt’s Lymphoma Fund for Africa was established two years ago, following a trip to East Africa where we saw first-hand the tragedy of children dying from this very aggressive form of cancer. It still amazes us that UPCID will be funding treatment for 300 Ugandan children and making a difference for a grant of less than $65,000 per year,” said Miriam Sevy, Board President of BLFA.

Direct Relief is supplying cancer treatment medications in collaboration with BLFA. The treatment program will begin in 2012.  Direct Relief is donating both medicines and related supplies to treat 300 children in Uganda and 250 children in Kenya.

The UCI/Hutchinson Center Cancer Alliance was formed in 2008 to spearhead research on cancers in the developing world with a special focus on infectious disease-related cancers. The collaboration concentrates on developing new models for the delivery of cancer care in resource-limited settings, and training the next generation of healthcare providers and researchers in infection-related cancers relevant to both sub-Saharan Africa and the United States.

Giving is Good Medicine

You don't have to donate. That's why it's so extraordinary if you do.